Tirofiban Hydrochloride Hydrate
14.05mg/50ml (12.5mg/50ml as tirofiban)
Co-administration with heparin in the patients who are:
– target patients in the treatment of acute coronary syndrome (ACS)
– patients with percutaneous transluminal coronary angioplasty (PTCA) or atherectomy
It has been shown to reduce the incidence of death, myocardial infarction, or combined endpoints of refractory ischemia/recardiac procedures.